tiprankstipranks
Silexion Therapeutics (SLXN)
NASDAQ:SLXN
US Market
SLXN
Silexion Therapeutics
RESEARCH TOOLSreports
Want to see SLXN full AI Analyst Report?

Silexion Therapeutics (SLXN) Income Statement

214 Followers

Silexion Therapeutics Income Statement

Last quarter (Q4 2025), Silexion Therapeutics's total revenue was $0.00, a decrease of ― from the same quarter last year. In Q4, Silexion Therapeutics's net income was $-4.41M. See Silexion Therapeutics’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 25Dec 24Dec 23Dec 22Dec 21
Total Revenue
$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Gross Profit
$ -14.00K$ 0.00$ 0.00$ 0.00$ 0.00
Operating Expenses
$ 11.63M$ 12.57M$ 4.68M$ 3.86M$ 943.93K
Depreciation and Amortization
$ 14.00K$ 25.00K$ 45.00K$ 57.00K$ 0.00
EBITDA
$ -11.62M$ -16.48M$ -4.64M$ -3.80M$ -755.00K
Operating Income
$ -11.63M$ -12.57M$ -4.68M$ -3.86M$ -943.93K
Other Income/Expenses
$ -277.00K$ -3.94M$ -395.00K$ 396.00K$ 188.72K
Pretax Income
$ -11.91M$ -16.51M$ -5.08M$ -3.46M$ -755.22K
Net Income
$ -11.91M$ -16.44M$ -4.94M$ -3.21M$ -755.22K
Per Share Metrics
Basic EPS
$ -8.96$ -2.64$ -4.42$ 0.03$ -0.05
Diluted EPS
$ -8.96$ -2.64$ -4.42$ 0.03$ -0.05
Weighted Average Shares Outstanding
 1.33M 6.24M 1.12M 16.73M 16.51M
Weighted Average Shares Outstanding (Diluted)
 1.33M 6.24M 1.12M 16.73M 16.51M
Currency in USD

Silexion Therapeutics Earnings and Revenue History